Chimerix Honored With "2011 Southeast BIO Deal of the Year: Venture Capital ... MarketWatch (press release) Clinical studies of CMX001 include an ongoing Phase 2 study of the prevention/control of CMV in adult hematopoietic stem cell transplant patients (CMX001-201); a Phase 2 study for the treatment of adenovirus infection in pediatric and adult ... |
